- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2026 · Mar 31, 2026 | $221K |
| Capex | Q1 2026 · Mar 31, 2025 | $981K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$144.92M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$105.89M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $753.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $893.37M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $865.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $972.13M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $668.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $629.84M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $51.25M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $50.63M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $214.9M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $214.83M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.02B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.13B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.08B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.19B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.73 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.73 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $24.39M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $15.93M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $100.89M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $106.45M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$120.85M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$115.36M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$125.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$122.37M |